Back to Search
Start Over
Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis
- Source :
- Arthritis Research & Therapy (formerly Arthritis Research); December 2011, Vol. 13 Issue: 3 pR74-R74, 1p
- Publication Year :
- 2011
-
Abstract
- Antinuclear antibodies (ANAs), usually detected by indirect immunofluorescence on HEp-2 cells, are identified in 90% of patients with systemic sclerosis (SSc). Thus, approximately 10% of SSc patients have no routinely detectable autoantibodies, and for 20% to 40% of those with detectable ANAs, the ANAs do not have identified specificity (unidentified ANAs). In this work, we aimed to identify new target autoantigens in SSc patients.
Details
- Language :
- English
- ISSN :
- 14786354 and 14786362
- Volume :
- 13
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Arthritis Research & Therapy (formerly Arthritis Research)
- Publication Type :
- Periodical
- Accession number :
- ejs25363846
- Full Text :
- https://doi.org/10.1186/ar3336